Posterior subcapsular cataract in patients with pemphigus and pemphigoid using oral corticosteroid;Catarata subcapsular posterior em pacientes com pênfigo e penfigóide tratados com corticoterapia oral

Anais Brasileiros de Dermatologia

Volumn 79, Issue 5, 2004, Pages 539-545

  Reggiani, Viviane ^a   Porro, Adriana Maria ^a   Alonso, Cristiane Ramos ^a   Dias, Adriana ^a   De Almeida, Fernando Augusto ^a  

^a Ambulatório de Dermatoses Bolhosas ^*

Author keywords

Adrenal cortex hormones therapeutic use; Cataract; Pemphigoid, bullous; Pemphigus

Indexed keywords

EID: 43149118001     PISSN: 03650596     EISSN: 18064841     Source Type: Journal    
DOI: 10.1590/S0365-05962004000500003     Document Type: Article

References (30)

1. Lever W F, White H. Treatmente of pemphigus with corticosteroids: results obteined in 46 patients over a period of 11 years. Arch Dermatol. 1963; 87:52-66.
2. Haim S, Shafrir A. Remarks on the treatment of pemphigus vulgaris. Dermatologica. 1970;141:270-6.
3. . Ryan JG. Pemphigus: a 20-year survey of experience with 70 cases. Arch Dermatol. 1971;104:14-20.
4. Rosenberg FR, Sanders S, Nelson CT. Pemphigus: a 20-year review of 107 patients treated with corticosteroids. Arch Dermatol. 1976; 112:962-70.
5. Cabrini JM, Margasin S, Mercau A, Recarte M, Vacirca E. Comentarios sobre un grupo de pacientes de penfigo atendidos en el policlinico I. Carrasco en los ultimos 10 años. Rev A rg Derm. 1984; 65:289-92.
6. Lapidoth M e cols. The efficacy of combined treatment with prednisone and cyclosporine in patients with pemphigus: preliminary study. J Am Acad Dermatol. 1994; 30(5 Pt1): 752-7.
7. Mourellou O e cols. The treatment of pemphigus vulgaris. Experience with 48 patients seen over an 11-year period. Br J Dermatol. 1995; 133:83-7.
8. Porro AM, Castro RM. Avaliação da resposta terapêutica e evolução em 40 doentes com pênfigo vulgar. Thesis paper. 1992; 140 p.
9. Cardama JE, Charosky CB, Jaled MM, Selva JS, Bassino BM, Baldanza R. Necrosis asética de cabeza de femur por corticoterapia prolongada en pacientes portadores de penfigo. Rev Arg Derm. 1981; 62:155-9.
10. D'Andreatta I. Exacerbação de balantidíase e estrongiloidíase em paciente com pênfigo foliáceo sul americano na vigência de corticoterapia. Ver Hosp Clin Fac Med S Paulo. 1980; 35:88-90.
11. Sarubbi F A. Hyperinfection with Strongyloides during treatment of pemphigus vulgaris. Arch Dermatol. 1987; 123:864-5 (Letter).
12. Ashworth J, Cox NH, Pickard WR, Mackay C, Roberts DT. Death in pemphigus vulgaris caused by lower gastrotrointestinal hemorrhage. J Am Acad Dermatol. 1987; 16: 394-5 (Letter).
13. Lauber JS, Abrams, HL, Ray MC. Silent bowel perforation occurring during corticosteroid treatment for pemphigus vulgaris. Cutis. 1989; 43: 27-8.
14. Epstein A, Trattner A, David M, Sandbank M. Perforation of colon diverticula during corticosteroid therapy for pembphigus vulvaris. Ann Pharmacother. 1993; 27: 979-80 (Letter).
15. Sharma R, Gupta KL, Ammon RH, Gambert SR. Departament of Medicine, New York Medical College, Valhalla, USA. A typical presentation of colon perforation related to corticosteroid use. Geriatrics. 1997; 52: 88-90.
16. Murdock DK, Lookingbill DP. Immunosuppressive therapy of pemphigus vulgaris complicated by Nocardia pneumonia. Arch Dermatol. 1990; 126:27-8.
17. Jack J Kanske. Chapter 8. In: Clinical Ophtalmologyc. Butterworth. Heinemann International Edition 1989; 234-59.
18. Black RL, Oglesby RB, von Sallmann L et al. Posterior subcapsular cataracts induced by corticosteroids in patients with rheumatoid arthritis. JAMA. 1960; 174:166-71.
19. Bihari M, Grossman BJ. Posterior subcapsular cataracts. Related to long-term corticosteroid treatment in children. Am J Dis Child. 1968; 116:604-8.
20. Havre DC. Cataracts in children on long-term corticosteroid therapy. Arch Ophthalmol. 1965; 3:818-21. 25.
21. Mino M, Ueda Y, Hayashi M et al. Posterior subcapsular cataract in children on longterm corticoid therapy. Acta Paediatr Jpn. 1969; 11:1-5.26.
22. Forman AR, Loreto JA, Tina LU. Reversibility of corticosteroid - associated cataracts in children with the nephrotic syndrome. A m J Ophtalmol. 1977; 84:75-8.
23. Dikshit SK, Avasthi PN. Posterior lenticular opacities in children on corticosteroid therapy. Indian J Pediatr. 1965; 32:93-6.
24. Loredo A, Rodriguez RS, Murillo L. Cataracts after short-term corticosteroid treatment. N Engl J Med. 1972; 286:160.
25. Rooklin AR, Lampert SI, Jaeger EA et al. Posterior subcapsular cataracts in steroid-requiring asthmatic children. J Allergy Clin Immunol. 1979; 63:383-6.
26. Skalka HW, Prchal JT. Effect of corticosteroids on cataract formation. Arch Ophthalmol. 1980; 98:1773-7.
27. Harris JE, Gruber L. The electrolyte and water balance of the lens. Exp Eye Res. 1962; 1:372-84.
28. Bucala R, Fishman J, Cerami A. Formation of covalent adducts bethewen cortisol and 16 alpha-hydroxyestrone and protein: possible hole in the pathogenesis of cortisol toxicity and systemic lupus erythematosus. Proc Natl Acad Sci USA. 1982; 79:3320-4.
29. Manabe S, Bucala R, Cerami A. Nonenzymatic addition of glucocorticoids to lens proteins in steroid-induced cataracts. J Clin Invest. 1984; 74:1803-10.
30. Bucala R, Manabe S, Urban RC Jr et al. Nonenzymatic modification of lens crystallins by predinisolone induces sulfhydryl oxidation and aggregate formation: In vitro and in vivo studies. Exp Eye Res. 1985; 41:353-63.